Figure (Pitavastatin Fig1)
Pitavastatin Tablet, Film Coated
Product Images NDC 65862-813
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Pitavastatin (NDC 65862-813). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Package Label Principal Display Panel (1 mg (90 Tablet Bottle))
Package Label Principal Display Panel (2 mg (90 Tablet Bottle))
Package Label Principal Display Panel (4 mg (90 Tablet Bottle))
NDC 65862-814-90 is the National Drug Code for Pitavastatin Tablets. Each film-coated tablet contains 4.18 mg of Pitavastatin calcium, which is equivalent to 4 mg of Pitavastatin. This medication is available in a bottle containing 90 tablets. The usual dosage should be followed as mentioned in the package insert for full prescribing information. It is recommended to store the tablets at a temperature between 20° to 25°C and protect them from moisture and light. The medication should be dispensed in a tight, light-resistant, and child-resistant container. It is distributed by Aurobindo Pharma USA, Inc. located in East Windsor, NJ, and made in India. However, the remaining text is not readable.*
Chemical Structure (Pitavastatin Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
